Immunotherapy for Urological Tumors on YouTubeTM: An Information-Quality Analysis

Bello, Francesco Di; Mauro, Ernesto Di; Ruvolo, Claudia Collà; Creta, Massimiliano; Rocca, Roberto La; Celentano, Giuseppe; Capece, Marco; Napolitano, Luigi; Fraia, Agostino; Pezone, Gabriele; Morra, Simone; Imbimbo, Ciro; Mirone, Vincenzo; Longo, Nicola; Califano, Gianluigi

doi:10.3390/vaccines11010092

Cited by 9 publications

(7 citation statements)

References 51 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…However, the medical content available on the internet is controversial and has not been properly examined. Di Bello et al [ 9 ] reported that YouTube videos have contributed to the spread of misinformation by underestimating the role of information on immunotherapy for urological tumors in a multimodality approach and missing the findings of published clinical trials. Not only were audiences not availing of accurate therapy, but also they were opting for therapies that may be harmful, which could lead to other complications [ 10 , 11 ].…”

Section: Introductionmentioning

confidence: 99%

Tumor Immunotherapy–Related Information on Internet-Based Videos Commonly Used by the Chinese Population: Content Quality Analysis

Ni,

Fei,

et al. 2024

JMIR Form Res

View full text Add to dashboard Cite

Background Tumor immunotherapy is an innovative treatment today, but there are limited data on the quality of immunotherapy information on social networks. Dissemination of misinformation through the internet is a major social issue. Objective Our objective was to characterize the quality of information and presence of misinformation about tumor immunotherapy on internet-based videos commonly used by the Chinese population. Methods Using the keyword “tumor immunotherapy” in Chinese, we searched TikTok, Tencent, iQIYI, and BiliBili on March 5, 2022. We reviewed the 118 screened videos using the Patient Education Materials Assessment Tool—a validated instrument to collect consumer health information. DISCERN quality criteria and the JAMA (Journal of the American Medical Association) Benchmark Criteria were used for assessing the quality and reliability of the health information. The videos’ content was also evaluated. Results The 118 videos about tumor immunotherapy were mostly uploaded by channels dedicated to lectures, health-related animations, and interviews; their median length was 5 minutes, and 79% of them were published in and after 2018. The median understandability and actionability of the videos were 71% and 71%, respectively. However, the quality of information was moderate to poor on the validated DISCERN and JAMA assessments. Only 12 videos contained misinformation (score of >1 out of 5). Videos with a doctor (lectures and interviews) not only were significantly less likely to contain misinformation but also had better quality and a greater forwarding number. Moreover, the results showed that more than half of the videos contain little or no content on the risk factors and management of tumor immunotherapy. Overall, over half of the videos had some or more information on the definition, symptoms, evaluation, and outcomes of tumor immunotherapy. Conclusions Although the quality of immunotherapy information on internet-based videos commonly used by Chinese people is moderate, these videos have less misinformation and better content. Caution must be exercised when using these videos as a source of tumor immunotherapy–related information.

show abstract

Section: Introductionmentioning

confidence: 99%

Tumor Immunotherapy–Related Information on Internet-Based Videos Commonly Used by the Chinese Population: Content Quality Analysis

Ni,

Fei,

et al. 2024

JMIR Form Res

View full text Add to dashboard Cite

show abstract

“…However, the analysis revealed no relevant differences between the videos dedicated to patients and the content addressed to healthcare workers; therefore, it is plausible that videos on mental health uploaded on YouTube™ are not a useful source of educational content for both the public and healthcare professionals. Furthermore, through an evaluation of the overall scores split by the years in which the videos were uploaded ( Figure 2 ), we observed that following the SARS-CoV-2 pandemic, both the number of videos and the quality or their content were unvaried, even though the global prevention measures adopted to contain the infection had fostered telemedicinal practices to support, educate, and address patients’ needs [ 35 , 36 ].…”

Section: Discussionmentioning

confidence: 99%

Mental Health of Prostate Cancer Patients: Content Review on YouTubeTM

Muzii

Bello

Carraturo

et al. 2023

IJERPH

Self Cite

View full text Add to dashboard Cite

The aim of this study is to evaluate YouTube™ content in terms of the quality of information available about prostate cancer (PCa) in relation to incidence, symptomatology, and potential treatments for patients’ mental health. We searched on YouTube™ for terms related to mental health combined with those relating to prostate cancer. Tools for audio–visual-content PEMAT A/V, Global Quality Score, and DISCERN score were applied for the assessment of videos’ quality. A total of 67 videos were eligible. Most of the analyzed YouTube™ videos were created by physicians (52.2%) in contrast to other author categories (48.8%). According to the PEMAT A/V, the median score for Understandability was 72.7% and the overall median score for Actionability was 66.7%; the median DISCERN score was 47, which correspond to a fair quality. Only videos focusing on the topic “Psychological Effects and PCa treatment” were significantly more accurate. The General Quality Score revealed that the majority of YouTube™ videos were rated as “generally poor” (21, 31.3%) or “poor” (12, 17.9%). The results suggest that the content of YouTube™ videos is neither exhaustive nor reliable in the current state, illustrating a general underestimation of the mental health of prostate cancer patients. A multidisciplinary agreement to establish quality standards and improve communication about mental health care is needed.

show abstract

“…Diese Daten belegen die hohen Kosten der Immuntherapie beim PCa [200]. Wir sehen in der Immuntherapie eine große Chance [201]. Allerdings müssen die Kosten dieser Behandlung gegen ihre Wirksamkeit abgewogen werden.…”

Section: Diskussionunclassified

Stand der Forschung und neue therapeutische Perspektiven in der Immuntherapie des Prostatakarzinoms

Maselli¹,

Giuliani²,

Laface³

et al. 2023

Kompass Onkol

View full text Add to dashboard Cite

Das Prostatakarzinom ist die häufigste Art von Tumor bei Männern. Im Frühstadium der Erkrankung ist es empfindlich gegenüber einer Androgenentzugstherapie. Bei Patienten mit metastasiertem kastrationssensitivem Prostatakarzinom (mHSPC) haben Chemotherapie und Androgenrezeptortherapien der zweiten Generation zu einer Verlängerung der Überlebenszeit geführt. Trotz der Fortschritte bei der Behandlung des mHSPC ist eine Kastrationsresistenz unvermeidlich, und viele Patienten entwickeln eine metastasierende kastrationsresistente Erkrankung (mCRPC). In den letzten Jahrzehnten hat die Immuntherapie die onkologische Landschaft dramatisch verändert und die Überlebensraten bei vielen Krebsarten erhöht. Allerdings hat die Immuntherapie beim Prostatakarzinom noch nicht die bahnbrechenden Ergebnisse gebracht, die sie bei anderen Tumorarten erzielt hat. Die Erforschung neuer Behandlungsmöglichkeiten ist für Patienten mit mCRPC aufgrund der schlechten Prognose sehr wichtig. In dieser Übersichtsarbeit konzentrieren wir uns auf die Gründe für die scheinbare intrinsische Resistenz des Prostatakarzinoms gegenüber der Immuntherapie, die Möglichkeiten zur Überwindung dieser Resistenz sowie die klinische Evidenz und auf neue therapeutische Perspektiven für die Immuntherapie des Prostatakarzinoms mit einem Blick in die Zukunft.

show abstract

Immunotherapy for Urological Tumors on YouTubeTM: An Information-Quality Analysis

Cited by 9 publications

References 51 publications

Tumor Immunotherapy–Related Information on Internet-Based Videos Commonly Used by the Chinese Population: Content Quality Analysis

Tumor Immunotherapy–Related Information on Internet-Based Videos Commonly Used by the Chinese Population: Content Quality Analysis

Mental Health of Prostate Cancer Patients: Content Review on YouTubeTM

Stand der Forschung und neue therapeutische Perspektiven in der Immuntherapie des Prostatakarzinoms

Contact Info

Product

Resources

About